| Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis J Stone, H Fraser, AG Lim, JG Walker, Z Ward, L MacGregor, A Trickey, ... The Lancet Infectious Diseases 18 (12), 1397-1409, 2018 | 211 | 2018 |
| HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment J Iversen, K Page, A Madden, L Maher JAIDS Journal of Acquired Immune Deficiency Syndromes 69, S176-S181, 2015 | 188 | 2015 |
| Uptake of hepatitis C treatment among people who inject drugs attending N eedle and S yringe P rograms in A ustralia, 1999–2011 J Iversen, J Grebely, L Topp, H Wand, G Dore, L Maher Journal of viral hepatitis 21 (3), 198-207, 2014 | 159 | 2014 |
| Estimating the cost-effectiveness of needle-syringe programs in Australia JA Kwon, J Anderson, CC Kerr, HH Thein, L Zhang, J Iversen, GJ Dore, ... Aids 26 (17), 2201-2210, 2012 | 126 | 2012 |
| Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia J Iversen, J Grebely, B Catlett, P Cunningham, GJ Dore, L Maher International Journal of Drug Policy 47, 77-85, 2017 | 122 | 2017 |
| The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis JA Kwon, J Iversen, L Maher, MG Law, DP Wilson JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (4), 462-469, 2009 | 109 | 2009 |
| Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia J Iversen, GJ Dore, B Catlett, P Cunningham, J Grebely, L Maher Journal of hepatology 70 (1), 33-39, 2019 | 93 | 2019 |
| Housing instability among people who inject drugs: results from the Australian needle and syringe program survey L Topp, J Iversen, E Baldry, L Maher, Collaboration of Australian NSPs Journal of Urban Health 90, 699-716, 2013 | 89 | 2013 |
| Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study J Iversen, H Wand, L Topp, J Kaldor, L Maher American journal of public health 103 (8), 1436-1444, 2013 | 82 | 2013 |
| Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modelling study JA Kwon, GJ Dore, J Grebely, B Hajarizadeh, R Guy, EB Cunningham, ... Journal of viral hepatitis 26 (1), 83-92, 2019 | 77 | 2019 |
| COVID‐19, HIV and key populations: cross‐cutting issues and the need for population‐specific responses J Iversen, K Sabin, J Chang, RM Thomas, G Prestage, SA Strathdee, ... African Journal of Reproduction and Gynaecological Endoscopy 23 (10), e25632, 2020 | 73 | 2020 |
| Prevalence and predictors of injecting‐related injury and disease among clients of Australia's needle and syringe programs L Topp, J Iversen, A Conroy, AM Salmon, L Maher, ... Australian and New Zealand journal of public health 32 (1), 34-37, 2008 | 60 | 2008 |
| Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia K Van de Ven, L Maher, H Wand, S Memedovic, E Jackson, J Iversen Drug and Alcohol Review 37 (7), 837-846, 2018 | 59 | 2018 |
| Are people who inject performance and image-enhancing drugs an increasing population of Needle and Syringe Program attendees? J Iversen, L Topp, H Wand, L Maher Drug & Alcohol Review 32 (2), 2013 | 58 | 2013 |
| Australian needle and syringe program national data report 2008–2012 J Iversen, L Maher The Kirby Institute, University of New South Wales. ISBN, 1448-5915, 2013 | 56 | 2013 |
| Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study H Bui, I Zablotska-Manos, M Hammoud, F Jin, T Lea, A Bourne, J Iversen, ... International Journal of Drug Policy 55, 222-230, 2018 | 52 | 2018 |
| Individual-level syringe coverage among Needle and Syringe Program attendees in Australia J Iversen, L Topp, H Wand, L Maher Drug and alcohol dependence 122 (3), 195-200, 2012 | 50 | 2012 |
| Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008 J Iversen, H Wand, A Gonnermann, L Maher International Journal of Drug Policy 21 (6), 471-476, 2010 | 50 | 2010 |
| Steroid users and the unique challenge they pose to needle and syringe program workers M Dunn, FH McKay, J Iversen Drug and Alcohol Review 33 (1), 71-77, 2014 | 49 | 2014 |
| Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey L Topp, J Iversen, H Wand, C Day, J Kaldor, L Maher, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (5), 632-638, 2008 | 48 | 2008 |
